Estimated proportion of HIV-exposed infants initiating cotrimoxazole prophylaxis over time, by province.</p
HIV-exposed infants and sites in the IeDEA consortium and Umoyo+, by region and country, 1997–2021.<...
*<p> = Year of study (if not available P = Year of publication).</p><p>CTX = Cotrimoxazole, HIV = H...
Objectives. To examine the influence of cotrimoxazole (CTM) prophylaxis on incidence of lower respi...
Estimated proportion of HIV-exposed infants initiating ARV prophylaxis over time, by province.</p
Estimated proportion of infants with HIV initiating ART over time, by province.</p
Estimated proportion of HIV-exposed infants receiving early infant diagnosis (EID) over time, by pro...
The World Health Organisation and the Joint United Nations Programme in 2006 reaffirmed the earlier ...
Estimated proportion of pregnant women receiving a subsequent test for HIV over time, by province.</...
Estimated proportion of pregnant women tested once for HIV over time, by province.</p
Indicators relating to care for HIV-exposed infants over time: (7) estimated proportion initiating A...
Estimated proportion of pregnant women with HIV on ART over time, by province.</p
Estimated proportion of pregnant women arriving in labour/delivery with unknown HIV status over time...
The World Health Organization guidelines recommend cotrimoxazole prophylactic treatment (CPT) for al...
HIV diagnosis rates by region of birth and exposure, with summary rate ratios, 2006–2015.</p
<p>Number of maternal STIs (chlamydia, gonorrhea, syphilis, CMV) Frequency distribution by infant HI...
HIV-exposed infants and sites in the IeDEA consortium and Umoyo+, by region and country, 1997–2021.<...
*<p> = Year of study (if not available P = Year of publication).</p><p>CTX = Cotrimoxazole, HIV = H...
Objectives. To examine the influence of cotrimoxazole (CTM) prophylaxis on incidence of lower respi...
Estimated proportion of HIV-exposed infants initiating ARV prophylaxis over time, by province.</p
Estimated proportion of infants with HIV initiating ART over time, by province.</p
Estimated proportion of HIV-exposed infants receiving early infant diagnosis (EID) over time, by pro...
The World Health Organisation and the Joint United Nations Programme in 2006 reaffirmed the earlier ...
Estimated proportion of pregnant women receiving a subsequent test for HIV over time, by province.</...
Estimated proportion of pregnant women tested once for HIV over time, by province.</p
Indicators relating to care for HIV-exposed infants over time: (7) estimated proportion initiating A...
Estimated proportion of pregnant women with HIV on ART over time, by province.</p
Estimated proportion of pregnant women arriving in labour/delivery with unknown HIV status over time...
The World Health Organization guidelines recommend cotrimoxazole prophylactic treatment (CPT) for al...
HIV diagnosis rates by region of birth and exposure, with summary rate ratios, 2006–2015.</p
<p>Number of maternal STIs (chlamydia, gonorrhea, syphilis, CMV) Frequency distribution by infant HI...
HIV-exposed infants and sites in the IeDEA consortium and Umoyo+, by region and country, 1997–2021.<...
*<p> = Year of study (if not available P = Year of publication).</p><p>CTX = Cotrimoxazole, HIV = H...
Objectives. To examine the influence of cotrimoxazole (CTM) prophylaxis on incidence of lower respi...